Optimized Biomimetic Syntheses of Discorhabdin B and Aleutianamine Drives a Deeper Exploration of Their Anticancer Potential

N Nicholas L. Magann (Department of Chemistry, 1102 Natural Sciences II) G Griffin L. Barnes (Department of Chemistry, 1102 Natural Sciences II) R Ryan Schioldager (Department of Chemistry, 1102 Natural Sciences II) F Fabian M. Hörmann (Department of Chemistry, 1102 Natural Sciences II) R Rubén Muñoz (Clinical Genomics and Therapeutics Division, Translational Genomics Research Institute (TGen), Part of City of Hope, Phoenix, Arizona 85004, United States) H Haiyong Han (Clinical Genomics and Therapeutics Division, Translational Genomics Research Institute (TGen), Part of City of Hope, Phoenix, Arizona 85004, United States) D Daniel Von Hoff (Clinical Genomics and Therapeutics Division, Translational Genomics Research Institute (TGen), Part of City of Hope, Phoenix, Arizona 85004, United States) C Christopher D. Vanderwal

Article Details

Volume / Issue Vol. 148, Issue 22
Published June 10, 2026
Pages 23280-23292
ISSN 0002-7863
Publisher American Chemical Society

Journal Info

Journal of the American Chemical Society

American Chemical Society

ISSN: 0002-7863 Physical Sciences

Authors (8)

N

Nicholas L. Magann

Department of Chemistry, 1102 Natural Sciences II

G

Griffin L. Barnes

Department of Chemistry, 1102 Natural Sciences II

R

Ryan Schioldager

Department of Chemistry, 1102 Natural Sciences II

F

Fabian M. Hörmann

Department of Chemistry, 1102 Natural Sciences II

R

Rubén Muñoz

Clinical Genomics and Therapeutics Division, Translational Genomics Research Institute (TGen), Part of City of Hope, Phoenix, Arizona 85004, United States

H

Haiyong Han

Clinical Genomics and Therapeutics Division, Translational Genomics Research Institute (TGen), Part of City of Hope, Phoenix, Arizona 85004, United States

D

Daniel Von Hoff

Clinical Genomics and Therapeutics Division, Translational Genomics Research Institute (TGen), Part of City of Hope, Phoenix, Arizona 85004, United States

C

Christopher D. Vanderwal